Quantcast

Latest Transplantation medicine Stories

2014-03-13 16:27:19

HORSHOLM, Denmark, March 13, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the U.S. FDA accepted for standard review the company's New Drug Application (NDA) for Envarsus(®) for the prevention of organ rejection in adult kidney transplant patients. Envarsus(®) is Veloxis' once-daily tacrolimus based on the company's proprietary MELTDOSE technology. Key points: -- FDA has set a target review date under the Prescription Drug User Fee Act (PDUFA)...

2014-03-12 20:24:35

DUBLIN, March 12, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/4v88mx/bone_grafts) has announced the addition of the "Bone Grafts - Global Strategic Business Report" [http://www.researchandmarkets.com/research/4v88mx/bone_grafts ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report analyzes the worldwide markets for Bone Grafts in US$ Million. The US market for Bone Graft...

2014-03-11 16:26:18

Results provide significant support to advance i-FACTOR(TM) Peptide Enhanced Bone Graft for FDA regulatory review. WESTMINSTER, Colo., March 11, 2014 /PRNewswire/ -- Cerapedics, Inc., an orthobiologics company focused on developing and commercializing novel peptide enhanced bone graft products based on its proprietary synthetic small peptide (P-15) technology platform, today presented preliminary outcomes data from a FDA Investigational Device Exemption (IDE) clinical trial for...

2014-03-11 16:25:46

EDISON, N.J., March 11, 2014 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF), the world's leading tissue bank today announced the recipients of its 2014 Research Grants. Since 1987, MTF has been at the forefront of research focused on the transplantation of donated human tissue, with approximately $38 million awarded through 2013. MTF anticipates awarding close to $2 million in grants and awards in the 2014 calendar year. The 2014 grant recipients approved for...

2014-03-07 23:21:07

OTTR™ Chronic Care Solutions, the leader in transplant patient tracking and data management software, is proud to announce that they have received official certification from the Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP) to submit, and retrieve, data using the AGNIS application and framework. Omaha, NE (PRWEB) March 07, 2014 The CIBMTR provides a unique resource of data for addressing important issues in...

2014-03-07 16:22:42

PHOENIX, March 7, 2014 /PRNewswire-USNewswire/ -- Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans. Recent developments in stem cell research have made it possible to assess its effect on intervertebral disc (IVD) height, Mayo Clinic researchers reported in a scientific poster today at the 30(th) Annual Meeting of the American...

2014-03-06 08:30:30

DUBLIN, Ireland, March 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/hp66zf/organ) has announced the addition of the "Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019" [http://www.researchandmarkets.com/research/hp66zf/organ ] report to their offering. The rise in incidences of organ failure in kidney, liver and heart patients across the globe is augmenting the...

2014-03-04 16:25:29

WESTMINSTER, Colo., March 4, 2014 /PRNewswire/ -- Cerapedics, Inc., an orthobiologics company focused on developing and commercializing novel peptide enhanced bone graft products based on its proprietary synthetic small peptide (P-15) technology platform, announced today that preliminary outcomes data from the company's FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR(TM) Peptide Enhanced Bone Graft will be presented at the Canaccord Genuity Musculoskeletal...

2014-03-04 16:25:27

CENTENNIAL, Colo., March 4, 2014 /PRNewswire-USNewswire/ -- AlloSource (allosource.org), one of the nation's largest providers of skin, bone and soft tissue allografts for use in surgical procedures, and the world's largest processor of cellular bone allografts, announced the donation of bone allografts to surgeons from Cincinnati Children's Hospital Medical Center who traveled to India to perform free surgeries for children afflicted with spine and upper extremity deformities. The...

2014-03-03 16:24:51

LONDON, March 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: UK Orthopedic Devices Market Report, 2005 - 2018Short Description The Market Intelligence report provides critical market data for UK orthopedic devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital "cross...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related